Fulton Bank N.A. Buys 366 Shares of The Procter & Gamble Company (NYSE:PG)

Fulton Bank N.A. boosted its position in The Procter & Gamble Company (NYSE:PG) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,630 shares of the company’s stock after purchasing an additional 366 shares during the quarter. Fulton Bank N.A.’s holdings in Procter & Gamble were worth $4,632,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Acorn Creek Capital LLC grew its position in shares of Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. boosted its stake in Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after buying an additional 59 shares during the last quarter. Traveka Wealth LLC grew its holdings in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC increased its stake in shares of Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after acquiring an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC raised its holdings in shares of Procter & Gamble by 11.2% during the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock worth $105,000 after acquiring an additional 61 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. This represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is owned by insiders.

Procter & Gamble Stock Performance

NYSE PG traded up $0.31 during trading on Wednesday, reaching $161.61. The company’s stock had a trading volume of 1,797,333 shares, compared to its average volume of 5,912,134. The business’s fifty day moving average price is $169.92 and its 200-day moving average price is $169.75. The Procter & Gamble Company has a twelve month low of $146.28 and a twelve month high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The firm has a market cap of $380.60 billion, a price-to-earnings ratio of 27.86, a P/E/G ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. The firm’s revenue for the quarter was down .6% on a year-over-year basis. As a group, analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

PG has been the subject of several recent analyst reports. Royal Bank of Canada restated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Morgan Stanley raised their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Piper Sandler initiated coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target for the company. Finally, Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $179.75.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.